ArkDTA: attention regularization guided by non-covalent interactions for explainable drug-target binding affinity prediction.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37387164.
- Also identified by DOI 10.1093/bioinformatics/btad207 and PMC identifier 10311339.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Protein-ligand binding affinity prediction is a central task in drug design and development. Cross-modal attention mechanism has recently become a core component of many deep learning models due to its potential to improve model explainability. Non-covalent interactions (NCIs), one of the most critical domain knowledge in binding affinity prediction task, should be incorporated into protein-ligand attention mechanism for more explainable deep drug-target interaction models. We propose ArkDTA, a novel deep neural architecture for explainable binding affinity prediction guided by NCIs. Experimental results show that ArkDTA achieves predictive performance comparable to current state-of-the-art models while significantly improving model explainability. Qualitative investigation into our novel attention mechanism reveals that ArkDTA can identify potential regions for NCIs between candidate drug compounds and target proteins, as well as guiding internal operations of the model in a more interpretable and domain-aware manner. ArkDTA is available at https://github.com/dmis-lab/ArkDTA. kangj@korea.ac.kr.
Medical subject headings
- Drug Design
- Drug Delivery Systems